Neuroendocrine tumor imaging just got a boost with both U.S Food and Drug Administration (FDA) and European Medicines Agency (EMA) orphan drug designation for gallium-68 DOTATATE, used in PET imaging of neuroendocrine cancer.

After waiting patiently for sodium F-18 fluoride PET/CT data to come out of the National Oncological PET Registry (NOPR), clinicians are now clear that that the scan benefits patients by changing their course of care, at the very least, 12 percent of the time, according to a review published March 10 in the Journal of Nuclear Medicine.

The Johnson and Johnson Innovation Center is bankrolling a research project with San Francisco-based Alector to prove feasibility of a monoclonal antibody agent that homes in on and treats Alzheimer’s disease processes in the brain, Alector announced yesterday.

Wayne, NJ, March 12, 2014 – Konica Minolta Medical Imaging will showcase Primary Imaging Solutions ideal for orthopedic practices at the upcoming American Academy of Orthopaedic Surgeons (AAOS) 2014 Annual Meeting, March 12-15 in New Orleans.  Two newly released systems, ImagePilot Aero and SONIMAGE P3, will be introduced for the first time to orthopedic surgeons. The company will also highlight the ImagePilot Sigma, a complete solution for practices looking to convert to digital radiography. Konica Minolta is exhibiting in booth 2641 at AAOS 2014.

Stamford, Conn., March 11, 2014 (Booth #2239 – Hall D) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will present its comprehensive portfolio of flat panel detectors at the American Association of Orthopaedic Surgeons (AAOS) Annual Meeting held March 12 – 14 in New Orleans, LA..

A grant amounting to $2.8 million has been awarded to Lightpoint Medical and surgical partners of the company headquartered in Rickmansworth, England, to bolster clinical trials for intraoperative imaging systems for prostate and breast cancer.

A voxel-based comparison of F-18 fluorothymidine (FLT) PET and MR spectroscopy revealed good contrast between tumorous and healthy tissues for both methods, according to a study presented during the scientific session of the 2014 European Congress of Radiology (ECR), which concludes today at Austria Center Vienna.

PET provides more detail than perfusion-weighted MRI about glioma tumor extent and metabolic activity, according to a study published online Feb. 27 in the Journal of Nuclear Medicine.